Neogen Corporation Finance Lease, Principal Payments
Neogen Corporation (NEOG) reported Finance Lease, Principal Payments of $100.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-07-30
- Neogen Corporation finance lease, principal payments for the quarter ending 2026-05-31 was $0.00, a 100.00% decline year-over-year.
- Neogen Corporation finance lease, principal payments for the quarter ending 2026-02-28 was $25.00K, a 7.41% decline year-over-year.
- Neogen Corporation finance lease, principal payments for the quarter ending 2025-11-30 was $0.00.
- Neogen Corporation finance lease, principal payments for the quarter ending 2025-08-31 was $75.00K.
- Neogen Corporation finance lease, principal payments for fiscal 2026 was $100.00K, a 66.67% decline from fiscal 2025.
- Neogen Corporation finance lease, principal payments for fiscal 2025 was $300.00K, a 50.00% increase from fiscal 2024.
- Neogen Corporation finance lease, principal payments for fiscal 2024 was $200.00K.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 9 month as first filed | Finance Lease, Principal Payments 12 month | Finance Lease, Principal Payments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $25.00K derived: sum of 2 quarters · filed 2026-07-30 | $25.00K derived: sum of 3 quarters · filed 2026-07-30 | $100.00K 10-K · filed 2026-07-30 | ||
| 2026-02-28 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $25.00K derived: sum of 2 quarters · filed 2026-04-09 | $100.00K 10-Q · filed 2026-04-09 | $200.00K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $75.00K 10-Q · filed 2026-01-08 | $175.00K derived: sum of 3 quarters · filed 2026-07-30 | $202.00K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-08-31 | $75.00K 10-Q · filed 2025-10-09 | $175.00K derived: sum of 2 quarters · filed 2026-07-30 | $202.00K derived: sum of 3 quarters · filed 2026-07-30 | |||
| 2025-05-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $127.00K derived: sum of 2 quarters · filed 2026-07-30 | $300.00K 10-K · filed 2026-07-30 | $298.00K 10-K · filed 2025-07-30 | ||
| 2025-02-28 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $200.00K 10-Q · filed 2026-04-09 | $248.00K 10-Q · filed 2025-04-09 | |||
| 2024-11-30 | $173.00K 10-Q · filed 2026-01-08 | |||||
| 2024-05-31 | -$148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$189.00K derived: sum of 2 quarters · filed 2026-07-30 | $200.00K 10-K · filed 2026-07-30 | $192.00K 10-K · filed 2024-07-30 | ||
| 2024-02-29 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | $348.00K 10-Q · filed 2025-04-09 | ||||
| 2023-11-30 | $389.00K 10-Q · filed 2025-01-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |